IPOs

US IPO Week Ahead: A 6-IPO week led by cannabis and the cloud

Six IPOs are set to raise $723 million in the week ahead, along with one SPAC.

Cloud-based software development platform Dynatrace (DT) is by far the largest, expected to raise over half of the week's proceeds at a $3.8 billion valuation. It's joined by a large early-stage cannabis producer (SNDL), a Chinese AR play (WIMI), a cancer biotech (RAPT), a US sushi chain (KRUS), and a micro-cap battery producer (FLUX).

Bought by Thoma Bravo for $2.5 billion in 2014, Dynatrace is raising $427 million at the $12 midpoint. While it will still carry substantial debt post-IPO, Dynatrace is profitable on an adjusted basis, and has so far successfully transitioned from selling on-prem software licenses to its new cloud-based SaaS (84% of MRQ sales).

Canadian cannabis producer Sundial Growers (SNDL) plans to list on the Nasdaq with a $1.6 billion market cap. With only $1 million in historical trailing sales, it expects to quickly ramp up in 2019 with its first harvest, while a recent acquisition gives it a foothold in the UK. Last year's cannabis IPO Tilray (TLRY) has traded down 40% in 2019, though it is still more than 140% above its offer price, at a valuation of over 100x LTM sales.

WiMi Hologram Cloud (WIMI) is targeting $34 million at a market cap of nearly $500 million. A leading player in China's holographic augmented reality space, the founder-owned company saw its sales jump 58% in the MRQ to $11 million, with a strong net margin of 48%.

Backed by The Column Group and Kleiner Perkins, RAPT Therapeutics (RAPT) is developing a therapies for difficult-to-treat cancers and inflammatory diseases.

Kura Sushi USA
(KRUS), being spun out of its Japanese parent (TSE: 2695), is targeting a market cap $123 million; the small chain (22 stores) believes that it can expand its footprint by 13x in the US, and aims to be the first US-based restaurant to IPO in four years.

Micro-cap battery maker Flux Power (FLUX) more than doubled its revenue to $6 million in the past 9 months, though it is highly unprofitable (-127% EBITDA margin).

Blank check company Netfin Acquisition (NFINU) is raising $220 million for a fintech business. It is led by Rick Maurer, founder and CEO of Longview Resources Group, and Martin Jaskel, a UK banker and director at European American Capital.

U.S. IPO Calendar
Issuer Business Deal Size Market Cap Price Range Shares Filed Top Bookrunners
WiMi Hologram (WIMI)Beijing, China $34M $496M $7.50 - $9.50 4,000,000 Benchmark Maxim
Chinese provider of ad services and software used in holographic augmented reality.
Dynatrace (DT)Waltham, MA $427M $3,771M $11 - $13 35,597,068 Goldman JP Morgan
Provides a software intelligence platform for the enterprise cloud.
Kura Sushi USA (KRUS)Irvine, CA $44M $123M $14 - $16 2,900,000 BMO Stephens
Operates 22 Japanese restaurants in the US featuring revolving sushi bars.
RAPT Therapeutics (RAPT)South San Francisco, CA $75M $359M $14 - $16 5,000,000 BofA ML Wells Fargo
Phase 1 biotech developing therapies for cancer and inflammatory diseases.
Sundial Growers (SNDL)Calgary, Canada $130M $1,607M $12 - $14 10,000,000 Cowen BMO
Early-stage Canadian cannabis producer.
Flux Power (FLUX)Vista, CA $13M $59M $9 1,449,275 Roth Cap. Maxim
Manufactures and sells lithium-ion batteries and storage solutions.
Netfin Acquisition Corp (NFINU)New York, NY $220M $281M $10 22,000,000 B. Riley FBR
Blank check company targeting a fintech business in an emerging market.

Sign up for a free trial of our premium platform, IPO Pro. Follow us on Twitter (@IPOtweet) and register for our updates on the IPO market.

IPOs are expected to price this week

Dynatrace Holdings

Flux Power Holdings

Kura Sushi USA

RAPT Therapeutics

Sundial Growers

WiMi Hologram Cloud

Netfin Acquisition Corp

Pre-IPO Research

IPO Market Snapshot

US IPO Week Ahead: A 6-IPO week led by cannabis and the cloud

Investment Disclosure: Renaissance IPO ETF (symbol: IPO) Renaissance International ETF (symbol: IPOS)

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.